Skip to content

Active ingredient

Gadoterate Meglumine

14 finished FDA listings contain Gadoterate Meglumine as their only active ingredient.

At a glance

From the FDA NDC Directory

Ingredient names as written by FDA
GADOTERATE MEGLUMINE
Dosage forms
Injection, Injection, Solution
Routes
Intravenous
Manufacturers / labelers
4
Strengths listed
376.9 mg/ml
Brand names in FDA listings
Clariscan, Dotarem

Official drug information

Source coverage for Gadoterate Meglumine:

  • FDA NDC Directory: linked
  • RxNorm: linked
  • Drugs@FDA: linked
  • DailyMed: linked

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 1421151

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

  • Application
    NDA 204781
    Sponsor
    GUERBET
    Original approval
    2013-03-20
    Listings
    5
  • Application
    ANDA 210016
    Sponsor
    GE HEALTHCARE
    Original approval
    2019-11-01
    Listings
    2
  • Application
    ANDA 215304
    Sponsor
    HENGRUI PHARMA
    Original approval
    2022-04-11
    Listings
    4
  • Application
    ANDA 218073
    Sponsor
    HAINAN POLY
    Original approval
    2024-06-17
    Listings
    2

Official labeling on DailyMed

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.